| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | Crizotinib | FIMM | pan-cancer | AAC | 0.55 | 0.0008 |
| mRNA | alisertib | CTRPv2 | pan-cancer | AAC | -0.1 | 0.001 |
| mRNA | ELCPK | CTRPv2 | pan-cancer | AAC | -0.16 | 0.001 |
| mRNA | Cytarabine | CTRPv2 | pan-cancer | AAC | -0.092 | 0.001 |
| mRNA | ceranib-2 | CTRPv2 | pan-cancer | AAC | -0.1 | 0.001 |
| mRNA | BRD-K28456706 | CTRPv2 | pan-cancer | AAC | -0.11 | 0.001 |
| mRNA | ciclopirox | CTRPv2 | pan-cancer | AAC | -0.1 | 0.002 |
| mRNA | Oxaliplatin | CTRPv2 | pan-cancer | AAC | -0.1 | 0.002 |
| mRNA | BIRB 0796 | FIMM | pan-cancer | AAC | 0.53 | 0.002 |
| mRNA | BMS-754807 | FIMM | pan-cancer | AAC | 0.38 | 0.002 |